Insulin Aspart Protamine And Insulin Aspart Injection, Suspension
Product Images NDC 73070-200
Product Visual Gallery
This gallery contains 36 technical images submitted to the FDA as part of the official labeling for Insulin Aspart Protamine And Insulin Aspart (NDC 73070-200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novo Nordisk Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Image 02)
Figure 3 (Image 03)
Vial Figure (Image 04)
Hand & Vial Figure (Image 36)
Figure A & Figure B (Image 37)
Figure C (Image 38)
Figure D (Image 39)
Figure E (Image 40)
Figure F (Image 41)
Figure G (Image 42)
Figure H (Image 43)
Figure I (Image 44)
Figure J (Image 45)
Image Of Possible Injection Sites. (Image 09)
Figure L (Image 47)
Figure M (Image 48)
Important (Image 10)
Insulin Aspart Protamine And Insulin Aspart Mix 70/30 Flexpen (Image 27)
Needle Components. (Image 05)
Pull Off The Pen Cap. (Image 50)
Roll The Pen Between Your Palms. (Image 51)
Move The Pen Up And Down. (Image 52)
Important (Image 11)
Figure D: Screw Needle On. (Image 06)
Figure E: Pull Off Outer Needle Cap. (Image 25)
Figure F: Pull Off Inner Needle Cap. (Image 26)
Turn The Dose Selector To 2 Units. (Image 56)
Fig. H (Image 13)
Press The Push-button. (Image 58)
Figure J (Image 28)
Press The Push Button To Inject. (Image 60)
Figure L (Image 07)
Replace The Pen Cap. (Image 62)
Vial Carton 8-0946-31-310-4 (Image 08)
Flexpen Carton 8-9674-31-310-7 (Image 12)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.